Loading…
It is a double-blind, randomized phase III prevention trial (parallel assignment) evaluating CP101 (oral application) vs placebo in adult patients with Clostridioides difficile infection (CDI) (recurrent)
Sustained Clinical Cure Through Week 8
No published results were found as of June 2026